Early changes in rat hearts with developing pulmonary arterial hypertension can be detected with three-dimensional electrocardiography

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 2, 2007, Pages

  Henkens, Ivo R ^a   Mouchaers, Koen T B ^b   Vliegen, Hubert W ^a   Van Der Laarse, Willem J ^b   Swenne, Cees A ^a   Maan, Arie C ^a   Draisma, Harmen H M ^a   Schalij, Ingrid ^b   Van Der Wall, Ernst E ^a   Schalij, Martin J ^a   Vonk Noordegraaf, Anton ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Electrocardiogram; Monocrotaline; Right ventricular hypertrophy

Indexed keywords

MONOCROTALINE;

ACTION POTENTIAL; ANATOMY; ANIMAL MODEL; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FORCE; HEART; HEART AFTERLOAD; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QRS COMPLEX; RAT; REPOLARIZATION; SYSTOLIC BLOOD PRESSURE; THREE DIMENSIONAL IMAGING; WISTAR RAT;

ACTION POTENTIALS; ANIMALS; BODY SURFACE POTENTIAL MAPPING; DISEASE MODELS, ANIMAL; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MONOCROTALINE; MYOCARDIAL CONTRACTION; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; SYSTOLE; TIME FACTORS; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 34547875763     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01359.2006     Document Type: Article

References (34)

1. Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, Takeshit A. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 94: 385-393, 2004.
2. Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC Jr. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 122: 524-527, 2002.
3. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43: 40S-47S, 2004.
4. Beek-Harmsen BJ, van der Laarse WJ. Immunohistochemical determination of cytosolic cytochrome C concentration in cardiomyocytes. J Histochem Cytochem 53: 803-807, 2005.
5. Bruner LH, Hilliker KS, Roth RA. Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat. Am J Physiol Heart Circ Physiol 245: H300-H306, 1983.
6. Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis 16: 13-18, 2005.
7. Chou TC. When is the vectorcardiogram superior to the scalar electrocardiogram? J Am Coll Cardiol 8: 791-799, 1986.
8. Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6: 698-702, 2000.
9. Des Tombe AL, Beek-Harmsen BJ, Lee-De Groot MB, van der Laarse WJ. Calibrated histochemistry applied to oxygen supply and demand in hypertrophied rat myocardium. Microsc Res Tech 58: 412-420, 2002.
10. Draisma HHM, Schalij MJ, van der Wall EE, Swenne CA. Elucidation of the spatial ventricular gradient and its link with dispersion of repolarization. Heart Rhythm 3: 1092-1099, 2006.
11. Draisma HHM, Swenne CA, Van de Vooren H, Maan AC, Hooft van Huysduynen B, van der Wall EE, Schalij MJ. LEADS: an interactive research oriented ECG/VCG. Comput Cardiol 32: 515-518, 2005.
12. Eddahibi S, Morrell N, d'Ortho MP, Naeije R, Adnot S. Pathobiology of pulmonary arterial hypertension. Eur Respir J 20: 1559 -1572, 2002.
13. Frank E. An accurate, clinically practical system for spatial vectorcardiography. Circulation 13: 737-749, 1956.
14. Frank E, Seiden GE. Comparison of limb and precordial vectorcardiographic systems. Circulation 14: 83-89, 1956.
15. Helm RA. Electrocardiographic cancellation: mathematical basis. Am Heart J 60: 251-265, 1960.
16. Helm RA, Chou TC. Electrocardiographic cancellation. A study of a single dipole at variable locations. Am Heart J 72: 218-237, 1966.
17. Hill NS, Warburton RR, Pietras L, Klinger JR. Nonspecific endothelinreceptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats. J Appl Physiol 83: 1209-1215, 1997.
18. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43: 13S-24S, 2004.
19. Kögler H, Hartmann O, Leineweber K, Nguyen van P, Schott P, Brodde OE, Hasenfuss G. Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat. Circ Res 93: 230-237, 2003.
20. Kossmann CE, Brody DA, Burch GE, Hecht HH, Johnston FD, Kay C, Lepeschkin E, Pipberger HV, Pipberger HV, Baule G, Berson AS, Briller SA, Geselowitz DB, Horan LG, Schmitt OH. Report of committee on electrocardiography, American Heart Association. Recommendations for standardization of leads and of specifications for instruments in electrocardiography and vectorcardiography. Circulation 35: 583-602, 1967.
21. + channels in rat heart with right ventricular hypertrophy. Am J Physiol Heart Circ Physiol 277: H1725-H1731, 1999.
22. Lehtonen J, Sutinen S, Ikaheimo M, Paakko P. Electrocardiographic criteria for the diagnosis of right ventricular hypertrophy verified at autopsy. Chest 93: 839-842, 1988.
23. Leineweber K, Brandt K, Wludyka B, Beilfuss A, Ponicke K, Heinroth-Hoffmann I, Brodde OE. Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure. Circ Res 91: 1056-1062, 2002.
24. Lourenco AP, Roncon-Albuquerque R Jr, Bras-Silva C, Faria B, Wieland J, Henriques-Coelho T, Correia-Pinto J, Leite-Moreira AF. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 291: H1587-H1594, 2006.
25. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, Loyd JE. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126: 14S-34S, 2004.
26. Okin PM, Kligfield P. Solid-angle theory and heart rate adjustment of ST-segment depression for the identification and quantification of coronary artery disease. Am Heart J 127: 658-667, 1994.
27. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107: 216-223, 1987.
28. Ritsema van Eck HJ, Kors JA, van Herpen G. Dispersion of repolarization, myocardial iso-source maps, and the electrocardiographic T and U waves. J Electrocardiol 39: S96-S100, 2006.
29. Roeleveld RJ, Marcus JT, Faes TJ, Gan TJ, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 234: 710-717, 2005.
30. Schermuly RT, Kreisselmeier KP, Ghofrani HA, Yilmaz H, Butrous G, Ermert L, Ermert M, Weissmann N, Rose F, Guenther A, Walmrath D, Seeger W, Grimminger F. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am J Respir Crit Care Med 169: 39-45, 2004.
31. Vonk-Noordegraaf A, Marcus JT, Gan CT, Boonstra A, Postmus PE. Interventricular mechanical asynchrony due to right ventricular pressure overload in pulmonary hypertension plays an important role in impaired left ventricular filling. Chest 128: 628S-630S, 2005.
32. Yuan JX, Rubin LJ. Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. Circulation 111: 534-538, 2005.
33. Zabel M, Malik M, Hnatkova K, Papademetriou V, Pittaras A, Fletcher RD, Franz MR. Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in male US veterans. Circulation 105: 1066-1070, 2002.
34. Zhang TT, Cui B, Dai DZ. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat. Acta Pharmacol Sin 25: 226-230, 2004.